查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008967

疫苗輸送裝置市場報告：按裝置、給藥途徑、最終用戶和地區分類（2026-2034 年）

Vaccine Delivery Devices Market Report by Device, Route of Administration, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2025年全球疫苗接種設備市場規模達85億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到147億美元，2026年至2034年的複合年成長率為6.03%。推動該市場穩步成長的因素包括：人們對疫苗接種的認知和需求不斷提高、無針注射器和微針等技術創新、感染疾病的蔓延以及主要企業之間持續的戰略合作。

疫苗接種設備市場趨勢：

感染疾病的傳播

全球流感、麻疹和新冠肺炎等感染疾病的日益流行，推動了疫苗需求的激增。 2021年，全球疫苗銷售量約為160億劑（價值1,410億美元），較2019年市場上流通的58億劑（約380億美元）顯著成長。這一成長主要由新冠肺炎疫苗推動，展現了疫苗生產規模化以滿足醫療需求的巨大潛力。因此，這對疫苗輸送裝置市場的收入產生了積極影響。此外，世界各國政府和衛生組織正將免疫接種作為預防疫情爆發和防止疾病跨國傳播的手段。這些積極措施增加了對先進疫苗輸送裝置的需求，以確保安全有效地接種疫苗。人們對疫苗接種重要性的高度認知以及由此帶來的高接種率，是推動先進疫苗輸送裝置需求的關鍵因素。此外，感染疾病的反覆爆發和大流行病的迫在眉睫的威脅，給研究人員和開發人員帶來了巨大的壓力，促使他們在給藥技術方面進行創新，這為疫苗輸送設備市場創造了光明的前景。

管理方法的技術進步

微針、無針注射器和經皮吸收貼片新型給藥技術的進步正在改變疫苗接種的模式。這些變革旨在提高疫苗的有效性、安全性和依從性。例如，微針貼片可實現無痛疫苗接種，且無需冷藏。此外，這些技術提升了使用者體驗，並消除了物流瓶頸。用於實際疫苗接種的智慧型設備進一步增強了這些優勢，實現了即時監測和劑量調整。疫苗接種設備市場概覽表明，該領域的持續創新正在吸引大量投資，並促成醫療設備製造商與研究機構之間的一系列合作。

政府措施和免疫計劃

政府的疫苗接種計劃和政策進一步推動了疫苗接種設備市場的成長。許多開發中國家和已開發國家都制定了嬰幼兒、兒童和成人的全面疫苗接種計劃，從而產生了對疫苗的需求，以預防各種感染疾病。為了確保疫苗能夠送達最終用戶，各國投入了大量的資金和其他資源。此外，世界衛生組織（世衛組織）和聯合國兒童基金會等國際衛生組織也為促進疫苗接種和支持開發中國家的免疫計畫做出了重要貢獻。這些組織負責疫苗和接種設備的採購和分發，並為醫護人員提供疫苗接種訓練。最近，非洲疾病預防控制中心和聯合國兒童基金會擴大了夥伴關係，以加強初級保健、供應鏈管理和聯合採購、本地生產以及緊急應變。根據疫苗接種設備市場報告，公共衛生部門對疫苗接種的持續關注正在創造對先進接種設備的需求，從而支撐著市場的穩定成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球疫苗輸送裝置市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依設備分類

  • 注射器
  • 噴射注射器
  • 其他

第7章 市場區隔：依給藥途徑

  • 肌肉內注射
  • 皮內接種
  • 皮下注射
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 診所
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Becton Dickinson and Company
    • Gerresheimer AG
    • Nanopass Technologies Ltd.
    • PharmaJet
    • SCHOTT Pharma
    • Terumo Corporation
    • Vaxxas
Product Code: SR112026A5933

The global vaccine delivery devices market size reached USD 8.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 14.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.03% during 2026-2034. The market is experiencing steady growth driven by the growing awareness and demand for vaccination, coupled with innovations such as needle-free injectors and microneedles, the rising prevalence of infectious diseases, and ongoing strategic collaborations among key players.

VACCINE DELIVERY DEVICES MARKET ANALYSIS:

  • Major Market Drivers: The escalating prevalence of infectious diseases and growing emphasis on vaccination programs are the major factors driving the vaccine delivery devices market. Besides this, the technological upgradation of delivery methods, such as microneedles and needle-free injectors are also favoring the market.
  • Key Market Trends: There is an increasing trend towards minimally invasive or painless delivery methods, with large investments in the R&D of novel devices. One of the other vaccine delivery devices market trends being witnessed is that numerous new and upcoming companies are focusing on creating smart delivery systems that can monitor and adjust the superfluous dosage in real-time.
  • Geographical Trends: North America and Europe dominate the market due to advanced healthcare infrastructure and a high rate of vaccination coverage. Asia-Pacific shows high growth due to increased healthcare expenditure and government initiatives in emerging markets.
  • Competitive Landscape: The market is moderately competitive; key players in the industry are focusing on strategic collaborations, mergers, and acquisitions to widen their current product portfolios. The major companies in this market are heavily investing in innovative delivery technologies.
  • Opportunities and Challenges: Major challenges are high regulatory requirements and high costs of advanced delivery devices, which may limit market penetration into developing regions. On the other hand, the vaccine delivery devices market recent opportunities lie in the increasing demand for combination vaccines and rising technologies that can increase both delivery efficiency and patient compliance.

VACCINE DELIVERY DEVICES MARKET TRENDS:

Increasing prevalence of infectious diseases

The demand for vaccines is escalating due to the growing prevalence of infectious diseases, such as influenza, measles, and COVID-19 in several regions globally. In 2021, approximately 16 billion vaccines worth US$ 141 billion were sold, compared to 5.8 billion doses circulating in the market in 2019, valued at an estimated US$ 38 billion. This growth was mainly driven by COVID-19 vaccines, showing the incredible potential of how vaccine manufacturing can be scaled up in answer to health needs. Therefore, this is positively influencing the vaccine delivery devices market revenue. Along with this, global governments and health bodies are focused on immunization as a preventive method for epidemics and a clamping brake on the spread of such diseases across borders. These proactive approaches increase the exigency for advanced vaccine delivery devices to ensure that vaccines are administered safely and effectively. High awareness about the importance of vaccination and subsequent high coverage of vaccination rate are important parameters propelling the demand for advanced vaccine delivery devices. Apart from this, recurrent outbreaks and the looming threat of pandemics exerting substantial pressure on researchers and developers for innovations in delivery technologies is creating a positive vaccine delivery devices market outlook.

Technological advancements in delivery methods

The advances in novel delivery technologies, such as microneedles, needle-free injectors, and transdermal patches, are changing the vaccine delivery landscape. Such changes have the objective of effectiveness, safety, and compliance. For instance, microneedle patches deliver vaccines painlessly and can even do so without reliance on refrigeration. In addition, the experience for the user is thus made more pleasant with technologies such as these, and free accounts of veto points in their logistics. This was further facilitated by the smart features of the devices used in the actual delivery of vaccines to allow for real-time monitoring and dosage adjustments. The vaccine delivery devices market overview suggests that continuous innovation in this field attracts a lot of investments and leads to a series of collaborations between medical device companies and research institutions.

Government initiatives and immunization programs

The vaccine delivery devices market growth is further driven by government vaccination programs and policies. Most of the developing and developed countries have set up elaborate vaccination programs for their infants, children, and adults, thus creating a demand for vaccines to prevent various infectious diseases. This is supported by vast financial and other resources to ensure the vaccines have gone to the grassroots. In addition, global health agencies such as the World Health Organization and UNICEF significantly facilitate the cause of vaccination and support developing countries' immunization programs. They provide procurement and distribution for both vaccines and their delivery devices, in addition to training health workers in vaccine administration. Recently Africa CDC and UNICEF expanded their partnership, which works on the strengthening of primary health care; supply chain management and pooled procurement; local manufacturing; and emergency response. According to the vaccine delivery devices market report, the consistent focus of public health authorities on vaccination ensures a lot of demand for advanced delivery devices, thereby supporting the steady growth of the market.

VACCINE DELIVERY DEVICES MARKET SEGMENTATION:

Breakup by Device:

  • Syringes
  • Jet Injectors
  • Others

Syringes account for the majority of the market share

Syringes dominate the devices that are used in the delivery of vaccines. The vaccine delivery devices market forecast suggests that they are relatively cheap and can be used to deliver any type of vaccine, making them the most widely and commonly used. Due to their reliability and familiarization with healthcare workers, traditional syringes have indeed played a very significant role in vaccination programs worldwide. Besides, the introduction of safety-engineered syringes, developed specifically to prevent needle-stick injuries and further reduce the risk of infecting oneself, has even advanced their dominance in the market. Their safety profile continued to be improved following the development of auto-disable syringes, as the technology of syringes advanced, further towards presenting the auto-disable syringes, which are designed for one-time use to conform to the single-use rule. This adaptability of these canulae to deliver vaccines with precise dosage and ease in both mass immunization campaigns and routine vaccination has made them important tools against infectious diseases. Ongoing investments concerning manufacturing capacity and other similar improvements to aseptic, ready-to-fill syringe-filling, and finishing capacity have also been put in place in a bid to ensure that the supply meets the increasing vaccine delivery devices demand, especially in situations following the outbreak of pandemics and emerging infectious diseases.

Breakup by Route of Administration:

  • Intramuscular Vaccination
  • Intradermal Vaccination
  • Subcutaneous Vaccination
  • Others

Intramuscular Vaccination holds the largest share of the industry

The segment of intramuscular (IM) vaccination holds the largest vaccine delivery devices market share in the route of administration for the market of vaccine delivery devices. This is majorly due to the wide acceptance of intramuscular vaccination, as it is effective in administering a wide range of vaccines. Vaccination into muscle tissue is relatively preferred, as many vasculatures in this tissue will help enhance the immune response of the antigen. This is completely appropriate with vaccines requiring penetration deeper into the tissue for optimal absorption and, therefore, the efficacy of the antigen, such as influenza, hepatitis, and COVID-19 vaccines. Moreover, ease of administration and means to use longer needles to get to the layer of muscle added to the reliability and standard of IM vaccination in both clinical and mass immunization settings. A continuing preference for the usage of IM injections is also related to their compatibility with the widest range of vaccine formulations, including liquid to lyophilized vaccines. In addition, technological progress in IM injection, including prefilled syringes and auto-injectors, is increasing its precision, safety, and ease, supporting the dominance of this route. According to the vaccine delivery devices market analysis, technological improvement in intramuscular injection, such as prefilled syringes, and autoinjectors, has significantly improved the precision, safety, and ease of this route, thereby supporting the dominance of this route.

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Hospitals represent the leading market segment

The largest end-use segment is hospitals in the vaccine delivery devices industry since they involve the real heart of vaccine administration and usually handle huge immunization programs. The key reason for this is that hospitals, being the primary setup of patient care, are abundant in human and material resources and infrastructures for handling the complexities of storage and the subsequent logistics involved in the further handling and administration of the vaccines. They play an extremely important role as points for routine and emergency immunization and preventive healthcare services. At a hospital, a patient gets the assurance of comprehensive care, including the ability to undertake any indicated medical procedure or intervention in the event of any adverse reactions, thus increasing safety and instilling confidence in the vaccination. Hospitals are also regularly checking vaccine delivery devices market recent developments during clinical trials and other research work. In addition, it is much easier to track and manage vaccination scheduling through the EHRs used in hospitals to ensure that there is broad protection for individuals, effective follow-up, and monitoring of immunization. It is, therefore, for this reason that they have the highest capacity for delivery and monitoring of vaccinations, thus being the largest end-use segment for the market for vaccine delivery devices.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the vaccine delivery devices industry include:

  • Becton Dickinson and Company
  • Gerresheimer AG
  • Nanopass Technologies Ltd.
  • PharmaJet
  • SCHOTT Pharma
  • Terumo Corporation
  • Vaxxas

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global vaccine delivery devices market in 2025?

2. What is the expected growth rate of the global vaccine delivery devices market during 2026-2034?

3. What are the key factors driving the global vaccine delivery devices market?

4. What has been the impact of COVID-19 on the global vaccine delivery devices market?

5. What is the breakup of the global vaccine delivery devices market based on the device?

6. What is the breakup of the global vaccine delivery devices market based on the route of administration?

7. What is the breakup of the global vaccine delivery devices market based on end user?

8. What are the key regions in the global vaccine delivery devices market?

9. Who are the key players/companies in the global vaccine delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vaccine Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device

  • 6.1 Syringes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Jet Injectors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Intramuscular Vaccination
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intradermal Vaccination
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Subcutaneous Vaccination
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Becton Dickinson and Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Gerresheimer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Nanopass Technologies Ltd.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 PharmaJet
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 SCHOTT Pharma
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Terumo Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Vaxxas
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio

List of Figures

  • Figure 1: Global: Vaccine Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Vaccine Delivery Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Vaccine Delivery Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Vaccine Delivery Devices Market: Breakup by Device (in %), 2025
  • Figure 5: Global: Vaccine Delivery Devices Market: Breakup by Route of Administration (in %), 2025
  • Figure 6: Global: Vaccine Delivery Devices Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Vaccine Delivery Devices Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Vaccine Delivery Devices (Syringes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Vaccine Delivery Devices (Syringes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Vaccine Delivery Devices (Jet Injectors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Vaccine Delivery Devices (Jet Injectors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Vaccine Delivery Devices (Other Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Vaccine Delivery Devices (Other Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Vaccine Delivery Devices (Intramuscular Vaccination) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Vaccine Delivery Devices (Intramuscular Vaccination) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Vaccine Delivery Devices (Intradermal Vaccination) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Vaccine Delivery Devices (Intradermal Vaccination) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Vaccine Delivery Devices (Subcutaneous Vaccination) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Vaccine Delivery Devices (Subcutaneous Vaccination) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Vaccine Delivery Devices (Other Routes of Administration) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Vaccine Delivery Devices (Other Routes of Administration) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Vaccine Delivery Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Vaccine Delivery Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Vaccine Delivery Devices (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Vaccine Delivery Devices (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Vaccine Delivery Devices (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Vaccine Delivery Devices (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: North America: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: North America: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United States: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United States: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Canada: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Canada: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Asia-Pacific: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Asia-Pacific: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: China: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: China: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Japan: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Japan: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: India: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: India: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: South Korea: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: South Korea: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Australia: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Australia: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Indonesia: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Indonesia: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Others: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Others: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Europe: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Europe: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Germany: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Germany: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: France: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: France: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: United Kingdom: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: United Kingdom: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Italy: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Italy: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Spain: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Spain: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Russia: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Russia: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Latin America: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Latin America: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Brazil: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Brazil: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Mexico: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Mexico: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Middle East and Africa: Vaccine Delivery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Middle East and Africa: Vaccine Delivery Devices Market: Breakup by Country (in %), 2025
  • Figure 76: Middle East and Africa: Vaccine Delivery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Global: Vaccine Delivery Devices Industry: SWOT Analysis
  • Figure 78: Global: Vaccine Delivery Devices Industry: Value Chain Analysis
  • Figure 79: Global: Vaccine Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Vaccine Delivery Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Vaccine Delivery Devices Market Forecast: Breakup by Device (in Million USD), 2026-2034
  • Table 3: Global: Vaccine Delivery Devices Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 4: Global: Vaccine Delivery Devices Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Vaccine Delivery Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Vaccine Delivery Devices Market: Competitive Structure
  • Table 7: Global: Vaccine Delivery Devices Market: Key Players